Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection
Abstract
Share and Cite
Morris, D.R.; Ansar, M.; Ivanciuc, T.; Qu, Y.; Casola, A.; Garofalo, R.P. Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection. Viruses 2020, 12, 1176. https://doi.org/10.3390/v12101176
Morris DR, Ansar M, Ivanciuc T, Qu Y, Casola A, Garofalo RP. Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection. Viruses. 2020; 12(10):1176. https://doi.org/10.3390/v12101176
Chicago/Turabian StyleMorris, Dorothea R., Maria Ansar, Teodora Ivanciuc, Yue Qu, Antonella Casola, and Roberto P. Garofalo. 2020. "Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection" Viruses 12, no. 10: 1176. https://doi.org/10.3390/v12101176
APA StyleMorris, D. R., Ansar, M., Ivanciuc, T., Qu, Y., Casola, A., & Garofalo, R. P. (2020). Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection. Viruses, 12(10), 1176. https://doi.org/10.3390/v12101176